During the past decade, Lungemedicinsk Forskningsafdeling. Aarhus University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lungemedicinsk Forskningsafdeling. Aarhus University Hospital" are "Allergy" (1 trials), "COVID-19" (1 trials), "Immune Tolerance" (1 trials) and "Injection Site Discomfort" (1 trials). Many other conditions were trialed in "Lungemedicinsk Forskningsafdeling. Aarhus University Hospital" in a lesser frequency.

Most popular intervention types in "Lungemedicinsk Forskningsafdeling. Aarhus University Hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.1 ml Isoton saline" (1 trials), "Alk (225) Phleum Pratense. 0.1 ml of 10,000 standard quantity units/ml." (1 trials) and "alk (225) Phleum Pratense. 0.1 ml of 10,000 standard quantity units/ml." (1 trials). Other intervention names were less common.

The vast majority of trials in "Lungemedicinsk Forskningsafdeling. Aarhus University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lungemedicinsk Forskningsafdeling. Aarhus University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Lungemedicinsk Forskningsafdeling. Aarhus University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lungemedicinsk Forskningsafdeling. Aarhus University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".